Share on Facebook Share on Twitter Email
Answers.com

Human serum albumin

 
Wikipedia: Human serum albumin
edit
Albumin
ALB structure.png
PDB rendering based on 1e7h.
Available structures
1ao6, 1bj5, 1bke, 1bm0, 1e78, 1e7a, 1e7b, 1e7c, 1e7e, 1e7f, 1e7g, 1e7h, 1e7i, 1gni, 1gnj, 1h9z, 1ha2, 1hk1, 1hk2, 1hk3, 1hk4, 1hk5, 1n5u, 1o9x, 1tf0, 1uor, 1ysx, 2bx8, 2bxa, 2bxb, 2bxc, 2bxd, 2bxe, 2bxf, 2bxg, 2bxh, 2bxi, 2bxk, 2bxl, 2bxm, 2bxn, 2bxo, 2bxp, 2bxq, 2esg, 2i2z, 2i30
Identifiers
Symbols ALB; DKFZp779N1935; PRO0883; PRO0903; PRO1341
External IDs OMIM103600 MGI87991 HomoloGene405
RNA expression pattern
PBB GE ALB 211298 s at tn.png
More reference expression data
Orthologs
Species Human Mouse
Entrez 213 11657
Ensembl ENSG00000163631 ENSMUSG00000029368
UniProt P02768 Q3TV03
RefSeq NM_000477 (mRNA) NM_009654 (mRNA)
NP_000468 (protein) NP_033784 (protein)
Location Chr 4:
74.49 - 74.51 Mb
Chr 5:
91.54 - 91.55 Mb
PubMed search [1] [2]

Human serum albumin is the most abundant protein in human blood plasma. It is produced in the liver. Albumin comprises about half of the blood serum protein. It is soluble and monomeric.

The gene for albumin is located on chromosome 4 and mutations in this gene can result in various anomalous proteins. The human albumin gene is 16,961 nucleotides long from the putative 'cap' site to the first poly(A) addition site. It is split into 15 exons which are symmetrically placed within the 3 domains that are thought to have arisen by triplication of a single primordial domain.

Albumin is synthesized in the liver as preproalbumin which has an N-terminal peptide that is removed before the nascent protein is released from the rough endoplasmic reticulum. The product, proalbumin, is in turn cleaved in the Golgi vesicles to produce the secreted albumin.

The reference range for albumin concentrations in blood is 30 to 50 g/L[1]. It has a serum half-life of approximately 20 days. It has a molecular mass of 67 kDa.

Contents

Functions of albumin

  • Maintains oncotic pressure
  • Transports thyroid hormones
  • Transports other hormones, particularly ones that are fat soluble
  • Transports fatty acids ("free" fatty acids) to the liver
  • Transports unconjugated bilirubin
  • Transports many drugs; serum albumin levels can affect the half-life of drugs
  • Competitively binds calcium ions (Ca2+)
  • Buffers pH
  • Serum albumin, as a negative acute-phase protein, is down-regulated in inflammatory states. As such, it is not a valid marker of nutritional status; rather, it is a marker in inflammatory states

Pathology

Hypoalbuminemia

Low blood albumin levels (hypoalbuminemia) can be caused by:

  • Liver disease; cirrhosis of the liver is most common
  • Excess excretion by the kidneys (as in nephrotic syndrome)
  • Excess loss in bowel (protein losing enteropathy e.g. Menetrier's)
  • Burns (plasma loss in the absence of skin barrier)
  • Redistribution (hemodilution [as in pregnancy], increased vascular permeability or decreased lymphatic clearance)
  • Acute disease states (referred to as a negative acute phase protein)
  • Mutation causing analbuminemia (very rare)

Hyperalbuminemia

Typically this condition is a sign of severe or chronic dehydration. Chronic dehydration needs to be treated with zinc as well as with water. Zinc reduces cell swelling caused by increased intake of water (hypotonicity) and also increases retention of salt. In the dehydrated state the body has too high of an osmolarity and apparently discards zinc to prevent this. Zinc also regulates transport of the cellular osmolyte taurine and albumin is known to increase cellular taurine absorption. Zinc has been shown to increase retinol (vitamin A) production from beta-carotene, and in lab experiments retinol reduced human albumin production.[2] It is possible that a retinol (vitamin A) deficiency alone could cause albumin levels to become raised. Patients recovering from chronic dehydration may develop dry eyes as the body uses up its vitamin A store. Interestingly, retinol causes cells to swell with water (this is likely one reason that too much vitamin A is toxic).[3]

Glycation (Glycosylation) of Serum Albumin

It has been known for a long time that human blood proteins like hemoglobin [4] and serum albumin [5][6] may undergo a slow non-enzymatic glycation, mainly by formation of a Schiff base between ε-amino groups of lysine (and sometimes arginine) residues and glucose molecules in blood (Maillard reaction). This reaction can be inhibited in the presence of antioxidant agents [7]. Although this reaction may happen normally [8] , elevated glycoalbumin is observed in diabetes mellitus [9].

Glycation has the potential to alter the biological structure and function of the serum albumin protein [10][11][12][13]. Moreover, the glycation finally can result in the formation of Advanced Glycosylation End Products (AGE), which result in abnormal biological effects. Accumulation of AGEs leads to tissue damage via alteration of the structures and functions of tissue proteins, stimulation of cellular responses, through receptors specific for AGE-proteins, and via generation of reactive oxygen intermediates. AGEs also react with DNA, thus causing mutations and DNA transposition. Thermal processing of proteins and carbohydrates brings major changes in allergenicity. AGEs are antigenic and represent many of the important neoantigens found in cooked or stored foods [14]. They also interfere with the normal product of nitric oxide in cells [15].

Although there are several lysine and arginine residues in the serum albumin structure, very few of them can take part in the glycation reaction [16][17]. It is not clear exactly why only these residues are glycated in serum albumin [18].

Testing for albumin loss via the kidneys

In the healthy kidney, albumin's size and negative electric charge exclude it from excretion in the glomerulus. This is not always the case, as in some diseases including diabetic nephropathy, a major complication of uncontrolled diabetes where proteins can cross the glomerulus. The lost albumin can be detected by a simple urine test.[19] Depending on the amount of albumin lost, a patient may have normal renal function, microalbuminuria, or albuminuria.

Amino Acid Sequence

The approximate sequence of human serum albumin is:

MKWVTFISLL FLFSSAYSRG VFRRDAHKSE VAHRFKDLGE ENFKALVLIA FAQYLQQCPF EDHVKLVNEV TEFAKTCVAD ESAENCDKSL HTLFGDKLCT VATLRETYGE MADCCAKQEP ERNECFLQHK DDNPNLPRLV RPEVDVMCTA FHDNEETFLK KYLYEIARRH PYFYAPELLF FAKRYKAAFT ECCQAADKAA CLLPKLDELR DEGKASSAKQ RLKCASLQKF GERAFKAWAV ARLSQRFPKA EFAEVSKLVT DLTKVHTECC HGDLLECADD RADLAKYICE NQDSISSKLK ECCEKPLLEK SHCIAEVEND EMPADLPSLA ADFVESKDVC KNYAEAKDVF LGMFLYEYAR RHPDYSVVLL LRLAKTYETT LEKCCAAADP HECYAKVFDE FKPLVEEPQN LIKQNCELFE QLGEYKFQNA LLVRYTKKVP QVSTPTLVEV SRNLGKVGSK CCKHPEAKRM PCAEDYLSVV LNQLCVLHEK TPVSDRVTKC CTESLVNRRP CFSALEVDET YVPKEFNAET FTFHADICTL SEKERQIKKQ TALVELVKHK PKATKEQLKA VMDDFAAFVE KCCKADDKET CFAEEGKKLV AASQAALGL

The italicized first 24 amino acids are signal and propeptide portions not observed in the transcribed, translated and transported protein but present in the gene. There are 609 amino acids in this sequence with only 585 amino acids in the final product observed in the blood.

See also

Interactions

Human serum albumin has been shown to interact with FCGRT.[20]

References

  1. ^ http://www.nlm.nih.gov/medlineplus/ency/article/003480.htm
  2. ^ Suzuki (July 2006). "All-trans retinoic acid down-regulates human albumin gene expression through the induction of C/EBPbeta-LIP". Biochem J. 397 (2): 345–53. doi:10.1042/BJ20051863. PMID 16608438. 
  3. ^ Gaull (December 1984). "Protective effect of taurine, zinc and tocopherol on retinol-induced damage in human lymphoblastoid cells.". J Nutr.. PMID 6502269. 
  4. ^ Rajbar S (1968). "An abnormal hemoglobin in red cells of diabetics". Clin Chim Acta 22 (2): 296–8. doi:10.1016/0009-8981(68)90372-0. PMID 5687098. 
  5. ^ Day J, Thorpe S, Baynes J (1979). "Nonenzymatically glucosylated albumin. In vitro preparation and isolation from normal human serum". J Biol Chem 254 (3): 595–7. PMID 762083. 
  6. ^ Iberg N, Flückiger R (1986). "Nonenzymatic glycosylation of albumin in vivo. Identification of multiple glycosylated sites". J Biol Chem 261 (29): 13542–5. PMID 3759977. 
  7. ^ Jakus V, Hrnciarová M, Cársky J, Krahulec B, Rietbrock N (1999). "Inhibition of nonenzymatic protein glycation and lipid peroxidation by drugs with antioxidant activity". Life Sci 65 (18-19): 1991–3. doi:10.1016/S0024-3205(99)00462-2. PMID 10576452. 
  8. ^ Day J, Thorpe S, Baynes J (1979). "Nonenzymatically glucosylated albumin. In vitro preparation and isolation from normal human serum". J Biol Chem 254 (3): 595–7. PMID 762083. 
  9. ^ Iberg N, Flückiger R (1986). "Nonenzymatic glycosylation of albumin in vivo. Identification of multiple glycosylated sites". J Biol Chem 261 (29): 13542–5. PMID 3759977. 
  10. ^ Mohamadi-Nejad A, Moosavi-Movahedi A, Hakimelahi G, Sheibani N (2002). "Thermodynamic analysis of human serum albumin interactions with glucose: insights into the diabetic range of glucose concentration". Int J Biochem Cell Biol 34 (9): 1115–24. doi:10.1016/S1357-2725(02)00031-6. PMID 12009306. 
  11. ^ Shaklai N, Garlick R, Bunn H (1984). "Nonenzymatic glycosylation of human serum albumin alters its conformation and function". J Biol Chem 259 (6): 3812–7. PMID 6706980. 
  12. ^ Mendez D, Jensen R, McElroy L, Pena J, Esquerra R (2005). "The effect of non-enzymatic glycation on the unfolding of human serum albumin". Arch Biochem Biophys 444 (2): 92–9. doi:10.1016/j.abb.2005.10.019. PMID 16309624. 
  13. ^ Mohamadi-Nejad A. et al. (2002). "The thermal analysisnext term of nonezymatic previous termglycosylation of human serum albumin:next term differential scanning calorimetry and circular dichroism studies". Thermochimica Acta 389 (1-2): 141–151. doi:10.1016/S0040-6031(02)00006-0. 
  14. ^ Kańska U, Boratyński J (2002). "Thermal glycation of proteins by D-glucose and D-fructose". Arch Immunol Ther Exp (Warsz) 50 (1): 61–6. PMID 11916310. 
  15. ^ Rojas A, Romay S, González D, Herrera B, Delgado R, Otero K (2000). "Regulation of endothelial nitric oxide synthase expression by albumin-derived advanced glycosylation end products". Circ Res 86 (3): E50–4. PMID 10679490. 
  16. ^ Iberg N, Flückiger R (1986). "Nonenzymatic glycosylation of albumin in vivo. Identification of multiple glycosylated sites". J Biol Chem 261 (29): 13542–5. PMID 3759977. 
  17. ^ Garlick R, Mazer J (1983). "The principal site of nonenzymatic glycosylation of human serum albumin in vivo". J Biol Chem 258 (10): 6142–6. PMID 6853480. 
  18. ^ Marashi S. A., Safarian S., Moosavi-Movahedi A.A. (2005). "Why major nonenzymatic glycation sites of human serum albumin are preferred to other residues?". Med Hypotheses 64 (4): 881. doi:10.1016/j.mehy.2004.11.007. PMID 15694713. 
  19. ^ Microalbumin Urine Test
  20. ^ Chaudhury, Chaity; Mehnaz Samina, Robinson John M, Hayton William L, Pearl Dennis K, Roopenian Derry C, Anderson Clark L (Feb. 2003). "The major histocompatibility complex-related Fc receptor for IgG (FcRn) binds albumin and prolongs its lifespan". J. Exp. Med. (United States) 197 (3): 315-22. ISSN 0022-1007. PMID 12566415. 

Further reading

  • Curry S (2003). "Beyond expansion: structural studies on the transport roles of human serum albumin.". Vox Sang. 83 Suppl 1: 315–9. PMID 12617161. 

External links


Search unanswered questions...
Enter a question here...
Search: All sources Community Q&A Reference topics
 
 

 

Copyrights:

Wikipedia. This article is licensed under the Creative Commons Attribution/Share-Alike License. It uses material from the Wikipedia article "Human serum albumin" Read more